SEARCH

SEARCH BY CITATION

References

  • Bennett DE, Mulhall RM & Cafferkey MT (2004) PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z. Journal of Clinical Microbiology 42, 17641765.
  • Bilukha OO & Rosenstein N (2005) Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Report 54, 121.
  • Boisier P, Nicolas P, Djibo S et al. (2007) Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clinical Infectious Diseases 44, 657663.
  • Claus H, Maiden MC, Wilson DJ et al. (2005) Genetic analysis of meningococci carried by children and young adults. The Journal of Infectious Diseases 191, 12631271.
  • Djibo S, Nicolas P, Alonso JM et al. (2003) Outbreaks of serogroup X meningococcal meningitis in Niger 1995–2000. Tropical Medicine and International Health 8, 11181123.
  • ECD Nouna (2005) Plan d’action 2006. District Sanitaire de Nouna.
  • Fonkoua MC, Taha MK, Nicolas P et al. (2002) Recent increase in meningitis caused by Neisseria meningitidis serogroups A and W135, Yaounde, Cameroon. Emerging Infectious Diseases 8, 327329.
  • Gagneux S, Hodgson A, Ehrhard I et al. (2000) Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana. Tropical Medicine and International Health 5, 280287.
  • Gagneux SP, Hodgson A, Smith TA et al. (2002) Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. The Journal of Infectious Diseases 185, 618626.
  • Greenwood B (1999) Manson Lecture. Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 341353.
  • Greenwood B (2007) The changing face of meningococcal disease in West Africa. Epidemiology and Infection 135, 703705.
  • Harrison LH, Jolley KA, Shutt KA et al. (2006) Antigenic shift and increased incidence of meningococcal disease. The Journal of Infectious Diseases 193, 12661274.
  • Leimkugel J, Hodgson A, Forgor AA et al. (2007a) Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana. PLoS Medicine 4, 05350544.
  • Leimkugel J, Forgor AA, Dangy JP et al. (2007b) Genetic diversification of Neisseria meningitidis during waves of colonization and disease in the meningitis belt of sub-Saharan Africa. Vaccine 25S, A1823.
  • Mueller JE, Sangare L, Njanpop-Lafourcade BM et al. (2007) Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003. Emerging Infectious Diseases 13, 847854.
  • Nicolas P, Decousset L, Riglet V et al. (2001) Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerging Infectious Diseases 7, 849854.
  • Nicolas P, Norheim G, Garnotel E, Djibo S & Caugant DA (2005) Molecular epidemiology of Neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes. Journal of Clinical Microbiology 43, 51295135.
  • Njanpop-Lafourcade BM, Parent DCI, Sanou O, Alonso JM & Taha MK (2005) The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso. Microbes and Infection 7, 645649.
  • Parent DCI, Traore Y, Gessner BD et al. (2005) Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clinical Infectious Diseases 40, 1725.
  • Peltola H (2001) Burden of meningitis and other severe bacterial infections of children in Africa: implications for prevention. Clinical Infectious Diseases 32, 6475.
  • Taha MK (2000) Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. Journal of Clinical Microbiology 38, 855857.
  • Taha MK, Achtman M, Alonso JM et al. (2000) Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356, 2159.
  • Taha MK, Parent DCI, Schlumberger M et al. (2002) Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. Journal of Clinical Microbiology 40, 10831084.
  • Teyssou R & Muroz-Le Rouzic E (2007) Meningitis in Africa: a brief overview. Vaccine 25S, A3A9.
  • Traore Y, Njanpop-Lafourcade BM, Adjogble KL et al. (2006) The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002–2005. Clinical Infectious Diseases 43, 817822.
  • Tsang RS, Henderson AM, Cameron ML et al. (2007) Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada. Journal of Clinical Microbiology 45, 17531758.
  • Whittle HC, Evans-Jones G, Onyewotu I et al. (1975) Letter: Group-C Meningococcal meningitis in the northern Savanna of Africa. Lancet i, 1377.
  • WHO (1999) Laboratory Methods for the Diagnosis of Meningitis Caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. WHO, Geneva.
  • WHO (2007) Risk of epidemic meningitis in Africa: a cause for concern. Weekly Epidemiological Record 82, 7987.
  • Yazdankhah SP, Kriz P, Tzanakaki G et al. (2004) Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. Journal of Clinical Microbiology 42, 51465153.
  • Ye Y, Gbangou A & Koyaté B (2002) Nouna DSS, Burkina Faso. in: Population and Health (ed. INDEPTH) International Development Research Center, Ottawa, pp. 221–226.